Abstract PurposeSeveral individual approaches were combined to fabricate a novel nanoparticulate drug delivery system to achieve targeting and anticancer effects in various malignant cancer cells. MethodsDoxorubicin was conjugated to Poly(lactic-co-glycolic acid) (PLGA), which was formulated into nanoparticle via solvent-diffusion method. The surface of the nanoparticles was subsequently linked with Poly(ethylene glycol) (PEG) and Arg-Gly-Asp (RGD) peptide to realize both passive and active targeting functions. The multifunctional nanoparticles were then tested against several malignant cancer cell lines. ResultsThe conjugation increased loading efficiency of doxorubicin to PLGA nanoparticles (the encapsulation efficiency was over 85�and alleviated the drug burst release effect substantially. The drug was released from the polymeric matrix in a sustained release manner over a period of 12 days. The resultant nanoparticles were spherically uniform and well-dispersed. The nanoparticle targeting ability was proven through strong affinity to various integrin-expressing cancer cells, and much less affinity to the low integrin expression cancer cells. The nanoparticles also showed high efficacy in inducing apoptosis in specific malignant cancer cell. ConclusionThe developed multifunctional nanoparticles hold potential to treat malignant integrin-expressing cancers.
drug delivery system1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Route_of_administration

nanoparticulate               0.911742742241028^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/nanoparticle          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

cancers                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cancer                

anticancer                    0.9999531182872654^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Chemotherapy          

conjugated                    0.9568199714897204^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Conjugated_system     

RGD                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Recognition_sequence  

cell                          0.9999999999998863^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_(biology)        

cancer cells                  0.9714675638631494^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer_cell           

doxorubicin                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Doxorubicin           

expression                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gene_expression       

malignant                     0.9999994307527714^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

matrix                        0.9999999999704414^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Extracellular_matrix  

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

malignant                     0.9999994307527714^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

drug                          0.9183923801307358^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

cancer cells                  0.9714675638631494^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer_cell           

affinity                      0.9934632852050662^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ligand_(biochemistry) 

sustained release             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Time_release_technology

cancer cells                  0.9714675638631494^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer_cell           

nanoparticle                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

peptide                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Peptide               

cancer                        0.702734711960099^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Cancer                

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

affinity                      0.9934632852050662^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ligand_(biochemistry) 

malignant                     0.9999994307527714^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

nanoparticle                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

drug                          0.9183923801307358^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

PEG                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Polyethylene_glycol   

cell lines                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cell_culture          

integrin                      0.8029394273221641^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_adhesion         

conjugation                   0.7790093812224871^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Conjugated_system     

malignant                     0.9999994307527714^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

Poly(lactic-co-glycolic acid) 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/PLGA                  

apoptosis                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Apoptosis             

ethylene glycol               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ethylene_glycol       

efficacy                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Efficacy              

encapsulation                 0.9999990442144073^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Capsule_(pharmacy)    

cancer                        0.702734711960099^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Cancer                

polymeric                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Polymer               

